Psych 06: NHP for Depression and Anxiety Syndromes

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/57

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:10 AM on 5/13/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

58 Terms

1
New cards

What NHPs are used for depression?

• St. John's Wort

• SAM-e

• Omega 3 Fatty Acids

• Folate

2
New cards

What NHPs are used for anxiety?

• Kava

• Passion Flower

• Bach Remedy

3
New cards

Can NHPs be used to augment?

maybe

4
New cards

What part of St. John's Wort is used?

the flower

5
New cards

What is the active constituent in SJW?

hyperforin

6
New cards

SJW MoA

• Inhibits reuptake of 5-HT, NE, DA, GABA and L-glutamate

• Reduce cytokine production (suggesting antiinflammatory MOA)

7
New cards

SJW evidence for mild-moderate MDD

• Superior to placebo in patients with mild-moderate major depression

• Similarly effective as standard anti-depressants

8
New cards

SJW evidence for severe MDD

insufficient to draw conclusions

9
New cards

SJW common AEs

- Dry mouth

- headache

- fatigue

- GI upset

- insomnia (take in AM)

10
New cards

SJW sexual dysfunction

Fewer ADRs than SSRIs and less sexual dysfunction.

11
New cards

SJW serious AEs

• Phototoxicity (avoid sun/ use sunscreen)

• Withdrawal syndrome (caution patient to taper) - Similar to SSRIs

• Mania, hypomania (AVOID in bipolar disorder)

12
New cards

What happens to the [drug] that are eliminated via CYP450 .. etc when adminstered w/ SJW?

- Reduces serum levels of susceptible drugs

- Decreases therapeutic effects

• > 45 drug interactions (19 MAJOR) and any other P-glycoprotein / P450 3A4 substrates

13
New cards

SJW effect on drug metabolism

Strong inducer of P-glycoprotein and CYP450 (mainly 3A4; but also 1A2, 2C19 and 2C9)

14
New cards

SJW DI

• Immuno-suppressants: cyclosporine

• Anti-retrovirals: reported to decrease plasma level of indinavir (57% decrease in AUC)

• Digoxin (up to 25% decrease in AUC)

• Opiates (methadone, oxycodone)

• Warfarin

• Oral contraceptives (many reports of pregnancies!)

• SSRIs and related anti-depressants

15
New cards

SJW dosing

Most clinical trials have used: 300 mg tid

(extract standardized to 0.3% hypericin and 2-5% hyperforin)

16
New cards

SJW time to effect

usually seen after 10 - 14 days (with significant clinical response seen at 4 - 6 wks)

17
New cards

What should be done when a patient wants to d/c SJW?

taper, due to risk of withdrawal syndrome

18
New cards

SAMe sources

- Found throughout the body: Amino acid derivative synthesized in the body from ATP and methionine

- Available from meat

- Produced synthetically

19
New cards

SAMe (S-adenosylmethionine) uses

MDD

osteoarthritis

20
New cards

SAMe MoA

an amino acid that acts as a universal methyl donor needed in the synthesis of monoamine transmitters (DA, NE and 5-HT) and membrane phospholipids

21
New cards

What are the effects of SAMe use on neurotransmission?

- increased NE, 5-HT & DA levels

- Alter cellular membrane fluidity helps with facilitation of signal transduction across membrane

- Anti-inflammatory effects

22
New cards

SAMe evidence vs TCA

Monotherapy with SAMe was comparable to TCAs, SSRI for mild-moderate MDD

23
New cards

SAMe evidence vs SSRI

may be a safe and effective adjunct to SSRIs for non-responders to SSRIs alone

24
New cards

Quality of SAMe evidence

Conclude: quality of trials was too low to make any recommendations

25
New cards

SAMe common SEs

Headache

dry mouth

insomnia

jitters (take in AM)

$$$

26
New cards

SAMe serious AEs

Possible mania & hypomania (in pts with bipolar disorder) - AVOID

27
New cards

Is serotonin syndrome a SE of SAMe?

Serotonin syndrome NOT reported in studies

28
New cards

SAMe dosing in mild-moderate MDD

800 mg po bid

29
New cards

O3FA MoA in MDD

Change membrane structure and function leading to:

- Improved cellular communication

- Reduced inflammatory processes (less PGE2)

- Improved neurotransmission

30
New cards

O3FA dosing in MDD

1 - 4 g EPA + DHA daily

Well tolerated at doses up to 3 g/d

31
New cards

Ratio of EPA:DHA that has been shown to be effective in the studies

supplements usually 3:2 (EPA>60%)

32
New cards

O3FA AEs

D, N, GI disturbance

33
New cards

O3FA DI

Hypotensive agents: can decrease blood pressure (additive effects)

34
New cards

How to reduce fishy aftertaste and belching?

Take with meals or freeze capsules before taking

35
New cards

Does O3FA prevent depression?

no evidence suggests this

36
New cards

O3FA monotherapy evidence

- Effective vs placebo (small-modest clinical effect)

- No difference in remission rates & QoL in some trials, similar adverse events to placebo

37
New cards

O3FA evidence as adjunct to SSRI

Mixed study results, safe to try?

38
New cards

Folate MoA for MDD

Body uses folate (from diet or synthetic) to make the active form, methyl folate, which then synthesizes monoamines (DA, NE, serotonin)

- Also required in the production of SAMe

39
New cards

Who might benefit from folate supplementation in MDD?

Some ppl may lack the gene that activates this enzymatic pathway and may benefit from supplementation

40
New cards

Folate evidence as adjunct

A number of small studies show improvement in depression when used as an adjunct with other treatments (200-500 mcg/d)

41
New cards

Does folate supplementation improve mood in ppl who are not deficient in this vitamin?

no

42
New cards

Folate safety

Well tolerated and safe when dose is below the UL (1000 mcg/d)

43
New cards

NICE guidelines 2022 regarding SJW

do not prescribe or advise its use

despite evidence of benefit, due to uncertain optimal doses, variations in preparations, potential serioius interactions

44
New cards

What NHPs can cause/exacerbate anxiety?

• Caffeine-containing natural medicines:

- black tea, coffee, guarana, yerba mate

• Synephrine-containing NHPs:

- Bitter orange

45
New cards

What is the main psychoactive constituent in Kava Kava?

Kavalactones

- Standardized to 30-70%

46
New cards

Kava MoA

Anxiolytic & sedative mechanisms largely unknown

47
New cards

Kava possible MoAs for anxiety

• Possibly increase effects of GABA by increasing number of GABA binding sites

• May inhibit uptake of NE

• Similar effects as benzo's but non-habit forming

48
New cards

Kava Kava safest duration of use

Appears to be safe if used for short durations (up to 8 weeks) - concern over hepatoxicity/liver failure

49
New cards

Kava SEs

GI upset

drowsiness

fatigue

HA

• May affect ability to drive

50
New cards

Kava drug-drug interactions

- CNS depressants

- alcohol

51
New cards

Kava drug-disease interactions

AVOID in patients with liver disease

- Long term effects of Kava and its relationship with hepatotoxicity need to be studied further

52
New cards

Kava evidence

Limited evidence shows better than placebo, but still many unknowns (duration, safety)

53
New cards

Kava dosing

120-240 mg PO OD standardized to 30-70% kavalactones

- May be more effective over 200 mg

54
New cards

Passion flower evidence for monotherapy in anxiety

Some +ve small trials showing comparable results to other anxiolytics (but onset of action believed to be longer)

55
New cards

Passion flower evidence for augment therapy in anxiety

Case studies show additive effects with barbiturates, CNS depressants, sertraline and lorazepam

56
New cards

Passion flower safest duration

Has been used safely for up to 8 wks

57
New cards

Bach remedy evidence for monotherapy

3 small studies showing no better than placebo

58
New cards

Bach remedy safety

Safe to try; effectiveness not proven